Eli Lilly & Co. (LLY)
988.64
+3.56
(+0.36%)
USD |
NYSE |
Mar 16, 16:00
987.51
-1.13
(-0.11%)
After-Hours: 18:21
Eli Lilly Market Cap : 882.85B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 197.46B |
| Regeneron Pharmaceuticals, Inc. | 79.99B |
| Viking Therapeutics, Inc. | 4.159B |
| Arcellx, Inc. | 6.696B |
| Moderna, Inc. | 21.06B |
Market Cap Related Metrics
| PE Ratio | 43.77 |
| PS Ratio | 13.82 |
| PEG Ratio | 0.4530 |
| Price to Book Value | 33.27 |
| Price to Free Cash Flow | 151.01 |
| Price | 988.64 |
| Earnings Yield | 2.28% |
| PEGY Ratio | 0.4500 |
| Operating PE Ratio | 30.33 |
| Normalized PE Ratio | 39.85 |